All filters
Slidesets
(Abstract) Predictors of HIV-testing in South African adolescents: schools-based testing, pregnancy and sexual experience | C. Carty
Presented at:
INTEREST 2016
Slidesets
Trial, post-trial, & demonstration project results for Pre-exposure Prophylaxis (PrEP) | Elizabeth Irungu, MBChB, MPH
Presented at:
INTEREST 2016
Slidesets
(Abstract) EDCTP as a model for Europe-Africa partnership on HIV/AIDS research and capacity development: Examples from Cameroon | L.J. Pandya
Presented at:
INTEREST 2016
Slidesets
Update on HIV vaccine strategies and trials: Active and passive immunization strategies | Hannah Kibuuka, MD
Presented at:
INTEREST 2016
Slidesets
Prevention Tools: Implementation and Discovery | Cissy Kityo, MD
Presented at:
INTEREST 2016
Slidesets
Drug Use in sub-Saharan Africa: opportunities and challenges | Reychad Abdool, MD
Presented at:
INTEREST 2016
Slidesets
(Abstract) Finding the first 90% to achieve epidemic control | J. Masedza
Presented at:
INTEREST 2016
Slidesets
Men who have sex with men in sub-Saharan Africa | Iliassou Mfochive Njindam, MD, MPH
Presented at:
INTEREST 2016
Slidesets
(Abstract) Operational research studies among MSM in Cameroon: Linkage to treatment challenges | U. Tamoufe
Presented at:
INTEREST 2016
Slidesets
(Abstract) Pre-Clinical Evaluation of optimized Immunogens targeting the neutralizing epitopes in MPER of HIV envelope Glycoprotein
Presented at:
INTEREST 2016
Slidesets
(Abstract) Identification of Rare HIV-1 Group N and HTLV-3 Strains in Rural South Cameroon | N. Ndembi
Presented at:
INTEREST 2016
Slidesets
Methods of MR fat quantification and their pros and cons | Michael Middleton, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
Noninvasive imaging methods for assessment of liver damage in NASH | Bachir Taouli, MD
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
NASH and Fibroscan | Raj Vuppalanchi, MD
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
O_04 - Blood-based Protein Biomarkers of NASH | Dr. S. Williams
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
O_05 - Validation of multiparametric MRI in the assessment and staging of non-alcoholic fatty liver disease | Dr. P. Eddowes
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
LiverMultiScan – quantitative MR imaging for NASH | Rajarshi Banerjee
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
O_06 - Longitudinal changes in FIB-4 and improvement in fibrosis stage with obeticholic acid: A secondary analysis of FLINT Trial | Dr. A. Sanyal
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
Need for Biomarker Development in Non-Alcoholic Fatty Liver Disease | Eric Lefebvre, MD
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
Principles of Biomarker Development | Margery Connelly, PhD, MBA
Presented at:
International Workshop on NASH Biomarkers 2016
Slidesets
Quantitative measures of liver health | Grey Everson, MD
Presented at:
International Workshop on NASH Biomarkers 2016